where is retatrutide approved produces up to 30.3% weight loss in Phase 3 trial Retatrutide for Weight Loss: What

Could retatrutide impact sleep or cause fatigue

How GLP-1s Offer Real-World Heart Protection The evidence that GLP1-s reduce the risk of heart attack and stroke comes from large cardiovascular outcomes trials designed to measure what researchers call MACE, major adverse cardiovascular events

The GLP-1 receptor activation promotes insulin secretion in a glucose-dependent manner, slows gastric emptying, and reduces appetite through central nervous system pathways

It is crucial to note that very low calorie diets (VLCDs) of less than 800 calories per day should only be followed under medical supervision within a structured, multicomponent weight management programme, as advised by NICE

All calculations are provided as-is without warranty

Diet plans for tirzepatide users emphasize high-protein meals to preserve lean mass, adequate hydration (both medications can increase fluid loss), and avoiding certain foods that worsen GI side effects